NCT06231238Active, not recruiting
Balance Acceptance and Commitment Therapy for Long COVID
A Randomised Controlled Trial Assessing the Efficacy of Balance Acceptance and Commitment Therapy (ACT) for Long COVID.
Source: ClinicalTrials.gov · Last updated 2 Jul 2026
Brief summary (registry, in English)
This randomised controlled trial aims to investigate the efficacy of a psychological intervention for long COVID (LC) / post-COVID-19 syndrome (PCS) called Balance Acceptance and Commitment Therapy (Balance ACT). The primary objective of this trial is to investigate whether Balance-ACT improves quality of life over treatment as usual (i.e., self-help leaflet) in people with PCS/LC.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 196 (estimated)
- First submitted
- 29 Jan 2024
- Start date
- 4 Jun 2024
- Primary completion date
- 30 May 2026
- Lead sponsor
- King's College London
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT06231238
What you commit to
- Study type: Interventional
- Planned participants: 196
- From 4 Jun 2024 to the primary completion date, 30 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Unstable alcohol / drug dependency
- Currently receiving psychological support or psychotherapy
Other illness
- Current diagnosis of an active major mental health disorder likely to interfere with participation
- Past hospitalisation for COVID-19
Other
- Unstable complications associated with LC/PCS
- Current or recent participation in other treatment intervention studies (\<4 weeks after completion)
- Pregnancy
Who the study is looking for
- Age 18 or older
- LC/PCS diagnosis as defined by National Health Service (NHS) / National Institute for Health and Care Excellence (NICE) (i.e., symptoms that develop during or after an infection consistent with COVID-19, continue for more than 12 weeks and are not explained by an alternative diagnosis). A checklist will be used to ensure participants fulfil the diagnostic criteria as per the NICE guidelines
- Ability to travel to the research site for the study assessments
- Having registered with a General Practitioner (GP) in the United Kingdom (UK) and consent to provide their details for the study team to contact
- Ability to provide informed consent
- Ability to read and write English
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| King's College London Coordinator of this site? Confirm its status | Camberwell | United Kingdom | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.